Icon Plc (NASDAQ: ICLR)’s stock price has plunge by -0.27relation to previous closing price of 138.85. Nevertheless, the company has seen a -4.63% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-05-07 that DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. As researchers uncover the pote.
Is It Worth Investing in Icon Plc (NASDAQ: ICLR) Right Now?
The price-to-earnings ratio for Icon Plc (NASDAQ: ICLR) is 15.07x, which is above its average ratio. Moreover, the 36-month beta value for ICLR is 1.23. Analysts have varying opinions on the stock, with 11 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for ICLR is 80.19M and currently, short sellers hold a 2.38% of that float. On May 09, 2025, ICLR’s average trading volume was 1.40M shares.
ICLR’s Market Performance
ICLR stock saw a decrease of -4.63% in the past week, with a monthly decline of -2.82% and a quarterly a decrease of -29.33%. The volatility ratio for the week is 4.75%, and the volatility levels for the last 30 days are 5.14% for Icon Plc (ICLR). The simple moving average for the past 20 days is -3.12% for ICLR’s stock, with a -39.51% simple moving average for the past 200 days.
Analysts’ Opinion of ICLR
Many brokerage firms have already submitted their reports for ICLR stocks, with JP Morgan repeating the rating for ICLR by listing it as a “Neutral.” The predicted price for ICLR in the upcoming period, according to JP Morgan is $150 based on the research report published on April 29, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see ICLR reach a price target of $157. The rating they have provided for ICLR stocks is “Hold” according to the report published on April 14th, 2025.
Barclays gave a rating of “Equal Weight” to ICLR, setting the target price at $165 in the report published on April 10th of the current year.
ICLR Trading at -15.29% from the 50-Day Moving Average
After a stumble in the market that brought ICLR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.18% of loss for the given period.
Volatility was left at 5.14%, however, over the last 30 days, the volatility rate increased by 4.75%, as shares sank -10.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.42% lower at present.
During the last 5 trading sessions, ICLR fell by -4.63%, which changed the moving average for the period of 200-days by -59.26% in comparison to the 20-day moving average, which settled at $142.94. In addition, Icon Plc saw -33.97% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICLR starting from Dr. John Climax, who proposed sale 140,000 shares at the price of $143.02 back on May 06 ’25. After this action, Dr. John Climax now owns shares of Icon Plc, valued at $20,022,800 using the latest closing price.
RONAN MARTIN MURPHY, the Officer of Icon Plc, proposed sale 1,540 shares at $187.07 during a trade that took place back on Mar 17 ’25, which means that RONAN MARTIN MURPHY is holding shares at $288,082 based on the most recent closing price.
Stock Fundamentals for ICLR
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.27 for the gross margin
The net margin for Icon Plc stands at 0.09. The total capital return value is set at 0.08. Equity return is now at value 8.01, with 4.49 for asset returns.
Based on Icon Plc (ICLR), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at 0.34. The debt to equity ratio resting at 0.37. The interest coverage ratio of the stock is 5.09.
Currently, EBITDA for the company is 1.56 billion with net debt to EBITDA at 1.98. When we switch over and look at the enterprise to sales, we see a ratio of 1.74. The receivables turnover for the company is 2.99for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
To wrap up, the performance of Icon Plc (ICLR) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
